• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三例拉莫三嗪治疗后可逆性粒细胞缺乏症。

Three cases of reversible agranulocytosis after treatment with lamotrigine.

机构信息

Department of Psychiatry, and Behavioral Science, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Psychiatry Investig. 2008 Jun;5(2):121-3. doi: 10.4306/pi.2008.5.2.121. Epub 2008 Jun 30.

DOI:10.4306/pi.2008.5.2.121
PMID:20046355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2796022/
Abstract

Several psychotropic drugs, including clozapine, are known to cause agranulocytosis and this may lead to a fatal condition. Lamotrigine is an anticonvulsant that the Food and Drug Administration (FDA) has approved for the depression of bipolar disorder. A few cases of lamotrigine-induced agranulocytosis have been previously reported on, but the pathophysiology and clinical manifestations are not yet known. This case series reports on 3 patients with different medical conditions who experienced agranulocytosis during treatment with lamotrigine. In these cases, the agranulocytosis occurred a few weeks after initiation of lamotrigine and it rapidly disappeared after discontinuation. We also discuss several characteristics of lamotrigine-induced agranulocytosis.

摘要

几种精神药物,包括氯氮平,已知可引起粒细胞缺乏症,这可能导致致命的情况。拉莫三嗪是一种抗惊厥药,食品和药物管理局(FDA)已批准用于治疗双相情感障碍的抑郁症。以前曾有报道过几例拉莫三嗪引起的粒细胞缺乏症,但病理生理学和临床表现尚不清楚。本病例系列报告了 3 例患有不同疾病的患者,他们在使用拉莫三嗪治疗期间发生了粒细胞缺乏症。在这些情况下,粒细胞缺乏症在开始使用拉莫三嗪几周后发生,并在停药后迅速消失。我们还讨论了拉莫三嗪引起的粒细胞缺乏症的几个特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c687/2796022/b4f6ca647038/pi-5-121-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c687/2796022/b4f6ca647038/pi-5-121-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c687/2796022/b4f6ca647038/pi-5-121-g001.jpg

相似文献

1
Three cases of reversible agranulocytosis after treatment with lamotrigine.三例拉莫三嗪治疗后可逆性粒细胞缺乏症。
Psychiatry Investig. 2008 Jun;5(2):121-3. doi: 10.4306/pi.2008.5.2.121. Epub 2008 Jun 30.
2
Rapid-onset agranulocytosis in a patient treated with clozapine and lamotrigine.一名接受氯氮平和拉莫三嗪治疗的患者出现快速发作的粒细胞缺乏症。
Psychiatr Danub. 2015 Sep;27 Suppl 1:S459-61.
3
Fatal agranulocytosis associated with psychotropic medication use.与精神药物使用相关的致命性粒细胞缺乏症。
Am J Health Syst Pharm. 2012 May 15;69(10):863-7. doi: 10.2146/ajhp110195.
4
[Antipsychotics in bipolar disorders].[双相情感障碍中的抗精神病药物]
Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5.
5
The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial.皮肤病预防措施对在双相I型障碍治疗中加用拉莫三嗪时皮疹发生率的影响:一项随机试验。
J Clin Psychiatry. 2006 Mar;67(3):400-6. doi: 10.4088/jcp.v67n0310.
6
[Agranulocytosis in the course of clozapine treatment].[氯氮平治疗过程中的粒细胞缺乏症]
Psychiatr Pol. 1995 Jan-Feb;29(1):67-77.
7
Carbamazepine-induced Life-threatening Stevens-Johnson Syndrome and Agranulocytosis: The Maiden Case.卡马西平诱发的危及生命的史蒂文斯-约翰逊综合征和粒细胞缺乏症:首例病例
J Clin Diagn Res. 2016 Dec;10(12):FD01-FD03. doi: 10.7860/JCDR/2016/23748.9065. Epub 2016 Dec 1.
8
Agranulocytosis associated with lamotrigine in a patient with low-grade glioma.一名低度胶质瘤患者出现与拉莫三嗪相关的粒细胞缺乏症。
Epilepsia. 2002 Feb;43(2):199-200. doi: 10.1046/j.1528-1157.2002.31801.x.
9
[Guidelines for the prescription of mood stabilizers for adolescents: A literature review].青少年情绪稳定剂处方指南:文献综述
Encephale. 2017 Oct;43(5):464-470. doi: 10.1016/j.encep.2016.09.005. Epub 2016 Nov 18.
10
Safety and tolerability of lamotrigine for bipolar disorder.拉莫三嗪治疗双相情感障碍的安全性和耐受性
Drug Saf. 2004;27(3):173-84. doi: 10.2165/00002018-200427030-00002.

引用本文的文献

1
Agranulocytosis Associated With Psychiatric Polypharmacy: Lessons Learned From a Clinical Case.与精神科联合用药相关的粒细胞缺乏症:从一例临床病例中吸取的教训。
Cureus. 2024 Mar 22;16(3):e56701. doi: 10.7759/cureus.56701. eCollection 2024 Mar.
2
Lamotrigine-induced neutropenia after high-dose concomitant initiation with phenytoin.高剂量拉莫三嗪与苯妥英钠同时起始治疗后出现的拉莫三嗪诱导的中性粒细胞减少症。
Clin Case Rep. 2021 Nov 22;9(11):e05136. doi: 10.1002/ccr3.5136. eCollection 2021 Nov.
3
Are clozapine blood dyscrasias associated with concomitant medications?

本文引用的文献

1
Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.双相情感障碍的治疗:针对一种多方面病症的复杂治疗。
Ann Gen Psychiatry. 2007 Oct 9;6:27. doi: 10.1186/1744-859X-6-27.
2
Possible bioactivation pathways of lamotrigine.拉莫三嗪可能的生物活化途径。
Drug Metab Dispos. 2007 Jul;35(7):1050-6. doi: 10.1124/dmd.107.015271. Epub 2007 Apr 4.
3
Psychotropic medications and leukopenia.精神药物与白细胞减少症。
氯氮平引起的血液系统异常与同时服用的药物有关吗?
Innov Clin Neurosci. 2011 Apr;8(4):35-41.
Curr Drug Targets. 2006 Sep;7(9):1191-4. doi: 10.2174/138945006778226642.
4
Lamotrigine-induced neutropenia.拉莫三嗪所致中性粒细胞减少症。
Can J Psychiatry. 2005 Mar;50(4):242. doi: 10.1177/070674370505000412.
5
Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results.“红色警戒区”中性粒细胞减少症患者维持氯氮平用药的经验:长期随访结果
Int Clin Psychopharmacol. 2004 Mar;19(2):97-101. doi: 10.1097/00004850-200403000-00007.
6
Agranulocytosis associated with lamotrigine in a patient with low-grade glioma.一名低度胶质瘤患者出现与拉莫三嗪相关的粒细胞缺乏症。
Epilepsia. 2002 Feb;43(2):199-200. doi: 10.1046/j.1528-1157.2002.31801.x.
7
Lamotrigine-associated neutropenia in a geriatric patient.老年患者中与拉莫三嗪相关的中性粒细胞减少症。
Am J Geriatr Psychiatry. 2000 Fall;8(4):346.
8
Agranulocytosis associated with lamotrigine.与拉莫三嗪相关的粒细胞缺乏症。
Am J Psychiatry. 2000 Oct;157(10):1704. doi: 10.1176/appi.ajp.157.10.1704.
9
Agranulocytosis associated with lamotrigine.与拉莫三嗪相关的粒细胞缺乏症。
BMJ. 1999 May 1;318(7192):1179. doi: 10.1136/bmj.318.7192.1179a.
10
Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.氯氮平所致粒细胞缺乏症。美国的发病率及危险因素。
N Engl J Med. 1993 Jul 15;329(3):162-7. doi: 10.1056/NEJM199307153290303.